GEN 7010
Alternative Names: GEN-7010Latest Information Update: 28 May 2023
At a glance
- Originator Suzhou GenAssist Therapeutics
- Class Gene therapies
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Beta-thalassaemia
Most Recent Events
- 10 May 2023 Preclinical trials in Beta-thalassaemia in China (Parenteral) (GenAssist Therapeutics pipeline, May 2023)